Shattuck Labs (STTK) Prepaid Assets (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Prepaid Assets of $3.3 million for Q1 2026, down 39.44% year-over-year from $5.5 million in Q1 2025, and down 24.4% quarter-over-quarter from $4.4 million in Q4 2025.
Shattuck Labs (STTK) Prepaid Assets (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Prepaid Assets for 8 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 39.44% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (down 39.44% YoY), while the FY2025 annual figure was $4.4 million, down 29.19% from the prior year.
- Prepaid Assets slipped to $3.3 million in Q1 2026 per STTK's latest filing, from $4.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $23.3 million in Q4 2022 and bottomed at $3.3 million in Q1 2026.
- Historically, Prepaid Assets has averaged $11.7 million across 5 years, with a median of $11.9 million in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 59.21% — and 2025, when it plunged 66.52%.
- Shattuck Labs' Prepaid Assets stood at $23.3 million in 2022, then slumped by 45.95% to $12.6 million in 2023, then plunged by 50.55% to $6.2 million in 2024, then retreated by 29.19% to $4.4 million in 2025, then decreased by 24.4% to $3.3 million in 2026.
- Business Quant data shows STTK's Prepaid Assets at $3.3 million in Q1 2026, $4.4 million in Q4 2025, and $4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.97 Mn |
| Mar 31, 2026 | 3.33 Mn |
| Dec 31, 2025 | 4.41 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 5.51 Mn |
| Dec 31, 2024 | 6.23 Mn |
| Sep 30, 2024 | 8.68 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 16.44 Mn |
| Dec 31, 2023 | 12.60 Mn |
| Sep 30, 2023 | 11.91 Mn |
| Jun 30, 2023 | 19.28 Mn |
| Mar 31, 2023 | 22.34 Mn |
| Dec 31, 2022 | 23.30 Mn |
| Sep 30, 2022 | 16.40 Mn |
| Jun 30, 2022 | 15.18 Mn |
| Mar 31, 2022 | 15.76 Mn |
| Dec 31, 2021 | 19.46 Mn |
| Sep 30, 2021 | 11.43 Mn |